Therapeutic challenges of oral mucositis in pediatric oncology

Authors

DOI:

https://doi.org/10.11606/issn.2176-7262.rmrp.2023.184330

Keywords:

Stomatitis, Chemotherapy, Oral hygiene, Low-intensity light therapy, Vitamin E, Mucositis

Abstract

Neuroblastoma (NB) is a neoplasia of the sympathetic nervous system and the second most common extracranial malignant solid tumor in childhood. In antineoplastic therapy, oral complications can be observed in antineoplastic therapy, among them oral mucositis (OM). It is an acute mucosa inflammation resulting from the toxicity of chemotherapy drugs. This case report emphasizes the management of OM and its influence on the systemic condition and quality of life. A female patient, nine years old, presented a recurrence of metastatic NB after first-line treatment.
She was admitted to the hospital unit for oncological therapy in the pediatric oncology ward, complaining of severe pain in the oral cavity and oropharynx associated with severe febrile pancytopenia. On physical examination, she presented dysphagia and severe weight deficit, which weakened the swallowing of her saliva. According to the World Health Organization (WHO), the intraoral exam revealed third-grade OM lesions on the lips, anterior gum, and oropharynx. Treatment consisted of removing local debris, cleaning the oral cavity with 0.12% chlorhexidine, and using a flexible, sterile cotton swab, aiming for daily local microbial control. In addition, photobiomodulation (660 nm, 50 mW, 2 J/cm2, 90 seconds) was applied to the erythematous and hemorrhagic bed, punctually in the areas of the lesion and sweeps in the oropharynx region (interspersed sessions). Racealphatocopherol acetate (vitamin E) was prescribed for antioxidant action and lip hydration. Concomitant with mucositis, the patient had severe febrile pancytopenia, requiring cefepime 150 mg/kg/day, with previous collection of blood cultures, granulocyte colonystimulating factor, fluconazole, hydration, and nutritional support. Blood cultures were negative. The consequences of mucositis contributed to malnutrition and worsened quality of life. It is concluded that the interdisciplinary dental intervention enabled physical and emotional restoration, enabling a better quality of life for the patient.

Downloads

Download data is not yet available.

Author Biographies

  • Iasminy Soares de Oliveira, Centro Universitário Governador Ozanam Coelho, Faculdade de Odontologia, Ubá, (MG), Brasil.

    Mestre. Professora Assistente

  • Larissa Pavan de Deus, Universidade Federal de Juiz de Fora, Faculdade de Odontologia, Juiz de Fora, (MG), Brasil.

    Acadêmica do curso de Odontologia

  • Tereza Cristina Esteves, Universidade Federal de Juiz de Fora. Faculdade de Medicina, Juiz de Fora, (MG), Brasil.

    Mestre. Professora do Departamento Materno Infantil

  • Maria das Graças Afonso Miranda Chaves, Universidade Federal de Juiz de Fora, Faculdade de Odontologia, Juiz de Fora, (MG), Brasil.

    Doutorado

  • Júlia Campos Fabri, Faculdade de Medicina e Ciências da Saúde de Juiz de Fora. Faculdade de Medicina, Juiz de Fora, (MG), Brasil

    Graduanda em Medicina

  • Gisele Maria Campos Fabri, Universidade Federal de Juiz de Fora, Faculdade de Odontologia, Juiz de Fora, (MG), Brasil.

    Pós-doutorado. Professora do Departamento de Clínica Odontológica

References

INCA- Instituto Nacional de Câncer. Câncer infantojuvenil. Última modificação: 25/05/2019. Disponível em: https://www.inca.gov.br/tipos-de-cancer/cancer-infantojuvenil. Acesso em: 25 out. 2019.

Tümmler C, Dumitriu G, Wickström M, Coopman P, Valkov A, Kogner P, Johnsen JI, Moens U, Sveinbjörnsson B. SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro. Cancers (Basel). 2019 Feb 10;11(2):202. doi: 10.3390/cancers11020202.

Tolbert VP, Matthay KK. Neuroblastoma: clinical and biological approach to risk stratification and treatment. Cell Tissue Res. 2018 May;372(2):195-209. doi: 10.1007/s00441-018-2821-2. Epub 2018 Mar 23.

Lucena JN, Alves MTS, Abib SCV, Souza GO, Neves RPC, Caran EMM. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF CHILDREN WITH NEUROBLASTOMA: 21 YEARS OF EXPERIENCE AT THE INSTITUTO DE ONCOLOGIA PEDIÁTRICA, IN SÃO PAULO, BRAZIL. Rev Paul Pediatr. 2018 Jul-Sep;36(3):254-260. doi: 10.1590/1984-0462/;2018;36;3;00007. Epub 2018 Jul 10.

Velten DB, Zandonade E, Monteiro de Barros Miotto MH. Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy. BMC Oral Health. 2017 Jan 20;17(1):49. doi: 10.1186/s12903-016-0331-8.

Guerrini-Rousseau L, Marec-Berard P, Bolle S, Laurent S. [Treatment of mucositis pain: News and prospects]. Bulletin du Cancer. 2019 Sep;106(9):776-783. DOI: 10.1016/j.

Daugėlaitė G, Užkuraitytė K, Jagelavičienė E, Filipauskas A. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis. Medicina (Kaunas). 2019 Jan 22;55(2):25. doi: 10.3390/medicina55020025.

Ribeiro da Silva VC, da Motta Silveira FM, Barbosa Monteiro MG, da Cruz MMD, Caldas Júnior AF, Pina Godoy G. Photodynamic therapy for treatment of oral mucositis: Pilot study with pediatric patients undergoing chemotherapy.

Photodiagnosis Photodyn Ther. 2018 Mar;21:115-120. doi: 10.1016/j.pdpdt.2017.11.010.

Kusiak A, Jereczek-Fossa BA, Cichońska D, Alterio D. Oncological-Therapy Related Oral Mucositis as an Interdisciplinary Problem-Literature Review. Int J Environ Res Public Health. 2020 Apr 3;17(7):2464. doi: 10.3390/ijerph17072464.

Wu KP, Ke JY, Chung CY, Chen CL, Hwang TL, Chou MY, Wong AM, Hu CF, Lee YC. Relationship between unstimulated salivary flow rate and saliva composition of healthy children in Taiwan. Chang Gung Med J. 2008 May-Jun;31(3):281-6.

Garrocho-Rangel JA, Herrera-Moncada M, Márquez-Preciado R, Tejeda-Nava F, Ortiz-Zamudio JJ, Pozos-Guillén A. Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series. Eur J Paediatr Dent. 2018 Sep;19(3):239-242. doi: 10.23804/ejpd.2018.19.03.13.

Venkatasalu MR, Murang ZR, Ramasamy DTR, Dhaliwal JS. Oral health problems among palliative and terminally ill patients: an integrated systematic review. BMC Oral Health. 2020 Mar 18;20(1):79. doi: 10.1186/s12903-020-01075-w.

WORLD HEALTH ORGANIZATION. Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization, 1979.

Hurrell L, Burgoyne L, Logan R, Revesz T, Gue S. The Management of Pediatric Oncology Inpatients With Oral Mucositis. J Pediatr Hematol Oncol. 2019 Nov;41(8):e510-e516. doi: 10.1097/MPH.0000000000001546.

Curra M, Soares Junior LAV, Martins MD, Santos PSDS. Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein (Sao Paulo). 2018;16(1):eRW4007. doi: 10.1590/s1679-45082018rw4007. Epub 2018 Apr 23.

Kwon Y. Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy. Onco Targets Ther. 2016 Apr 5;9:2007-16. doi: 10.2147/OTT.S96899.

ELAD, S. et al. ” MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy.” Cancer, 2020.

Altiner A, Atalay H, Bilal T. Vitamin E as an antioxidant. Balikesir Health Science Journal 2017;6(3):149-157.

O'Connor A, Lopez MJ, Eranki AP. Cefepime. 2020 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan.

Gustinetti G, Mikulska M. Bloodstream infections in neutropenic cancer patients: A practical update. Virulence. 2016 Apr 2;7(3):280-97. doi: 10.1080/21505594.2016.1156821.

Published

2023-08-15

Issue

Section

Relato de Caso

How to Cite

1.
Oliveira IS de, Deus LP de, Esteves TC, Chaves M das GAM, Fabri JC, Fabri GMC. Therapeutic challenges of oral mucositis in pediatric oncology. Medicina (Ribeirão Preto) [Internet]. 2023 Aug. 15 [cited 2024 May 16];56(2):E-184330. Available from: https://www.revistas.usp.br/rmrp/article/view/184330